Students from Al-Yamamah University discussed the financial contradictions in the results of the pharmaceutical services company for the first quarter of 2026; where net profit fell by 78% to record 22.53 million riyals under pressure from seasonal sales and exceptional government expenses amounting to 27 million riyals. In contrast, the company injected extensive investments in branches and the digital platform, achieving record growth exceeding 50% in the wholesale and logistics sectors.
Market Share and Income Diversification for the Business Sector
Student "Ghada Alsarheed" @Ghada Alsarheed opened the analysis by posing marketing and financial questions, stating: "In my opinion, there is a question we need to consider: what do we want, investment or profits? Sacrificing current quarter profits is a correct and smart decision; because investing in branches and the digital platform protects market share for the future, and not investing today means death tomorrow in front of competitors. There are two points we can think about regarding the puzzle of 27 million riyals: when viewed from a financial analyst's perspective, some points are excluded when evaluating true operational performance because they are exceptional and non-recurring expenses, and do not reflect weakness in sales or marketing efficiency. However, from a marketing perspective, we see it as income diversification; the growth of the wholesale and logistics sector by over 50% is a lifeline when the company smartly transforms from just a retail pharmacy to a massive supply platform for the business sector (B2B), protecting it from fluctuations in individual sales. In conclusion: the drop in profits is temporary and serves as a battery recharge for the transition to an integrated health and logistics system, working on a multi-dimensional perspective to find practical solutions. However, it is not necessarily the case that a decline in profits is always the solution; continued declines can be harmful in the long run, and they need to think about how to reduce loss ratios, consider ways to increase profits and compensation, and think about other sectors and business sectors at both the internal and external levels of the Kingdom, and whether the loss was due to war, political, and management conditions or other circumstances, and not reflecting it on the beneficiaries to maintain long-term benefits for all parties."
Return on Expansions and Long-Term Investors
On his part, student "Yousef Fares" @Yousef Fares focused on the quality of future growth, stating: "In my opinion, what the company did makes sense if the current expansions can achieve higher returns in the future, because long-term investors care more about the quality of growth than profits for one quarter. As for the non-recurring government expenses of 27 million riyals, I exclude them when evaluating operational performance because they do not reflect the profitability of the core activity. Regarding income diversification, I see that the growth of the wholesale and logistics sectors by more than 50% is a positive indicator, as it reduces reliance on pharmacies and provides the company with more diverse and sustainable income sources. In conclusion: the drop in profits is concerning, but the important thing is whether the current investments will turn into stronger profits and cash flows in the coming periods."
The Audit Chapter and the Strength of Operational Position
Student "Fay Aldossari" @Fay Aldossari shared a thorough and deep view of the numbers, clarifying: "What happened with the company can be summarized in two words: a temporary decline for a future leap. Is a 78% drop in profits a cause for concern? No; because the drop is not due to a failure in sales operations, but because they injected significant cash liquidity into establishing new branches and developing the application and digital platform. From an accounting perspective, these expenses will bring cash flows and expand the business size in the coming years. The story of the 27 million riyals related to government expenses is a one-time hit and ended as it is a non-recurring expense; as a financial analyst, it should be excluded from the calculation to see the true profits of the company, and then we will discover that their operational position is much better than what appears on the screen. As for the logistics and wholesale sector, this is the new winning card for the company; the traditional pharmacy market has become crowded with strong competition, and it is smart management that transformed its warehouses and transport fleet into an independent activity serving the entire medical market, and the growth of this sector by over 50% proves that the plan is on the right track. In conclusion: management sacrificed this quarter's profits to ensure future leadership, and the stock may be pressured by the market in the short term as a reaction to the numbers, but strategically, the company is building correctly."
Expert Opinion:
Professor Abdulaziz Khrais believes that the "pharmaceutical" company recorded results that are not good with a net profit of 22.53 million for the first quarter of 2026, noting that the company was late in publishing its results and did not adhere to the publication deadline; which created a state of concern among shareholders. These profits are the lowest since the company was listed in the market, while revenues are the lowest since the first quarter of 2024.
Khrais explains that the decline in revenues contributed to the decrease in net profit alongside other factors described by the company as non-recurring expenses; the most notable of which is due to recording government expenses of 27 million riyals related to renewing residency and work permits for 93% of the company's non-Saudi employees. At the same time, the board of directors sent a message of reassurance to shareholders by announcing the distribution of dividends to shareholders for the first quarter of 2026 at the same amount each quarter of 63 halalas per share, noting that the entitlement date is set for next month. We leave the question open for interested parties: Dear reader, do you see that the sustainability of cash distributions is sufficient to dispel concerns about the decline in operational profits, or does the delay in financial statements require greater caution?"
Comments (11)
No comments yet. Be the first to comment!